Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has helped millions lose weight, yet approximately 20-30% of patients experience either poor initial response or weight loss plateaus after several months of treatment. If you're taking Wegovy but not seeing the results you expected, the problem may not be willpower—it could be a mismatch between your body's peptide pathways and your current medication approach.

Why GLP-1 Medications Sometimes Fail to Deliver Results

Not everyone's body responds to standard GLP-1 therapy the same way. Wegovy and similar injectable semaglutides work by mimicking glucagon-like peptide-1, a hormone that signals fullness and slows digestion. However, individual differences in how your body produces, processes, and responds to this hormone can affect treatment success. Some patients have naturally lower GLP-1 receptor sensitivity, meaning they may need higher doses or alternative compounds to achieve meaningful weight loss.

Common reasons for stalled progress include inadequate dosing escalation, medication tolerance over time, and underlying metabolic factors that standard treatment doesn't address. Additionally, Wegovy's fixed dosing schedule may not align with your body's specific peptide needs. PlexusDx recognizes that cookie-cutter dosing fails many patients, which is why compounded semaglutide injection allows flexible dose adjustment without price increases—your dose may need to go up, but your price won't.

Lifestyle factors also play a role: if you're not in a calorie deficit, managing stress, or getting adequate sleep, even the right medication won't overcome those barriers. A holistic weight loss approach combines medication optimization with behavioral change.

How Genetic Factors Influence Your Weight Loss Response

Your DNA significantly impacts how effectively GLP-1 medications work for you. Key genetic variants in the GLP1R gene (like rs6923761) affect how sensitive your cells are to semaglutide signaling, while variants in the FTO gene (rs9939609) influence your baseline appetite regulation and metabolic rate. The GIPR gene variant (rs1800437) determines your response to glucose-dependent insulinotropic polypeptide—a hormone that works alongside GLP-1 in your body. If you carry less favorable variants in these genes, standard semaglutide alone may produce disappointing results.

PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides and 150+ genetic insights, revealing exactly which weight loss mechanisms your body will respond to best. For example, if genetic testing shows weak GLP1R signaling but strong MC4R (melanocortin-4 receptor) pathway activity, you might benefit more from tirzepatide—a dual GIP/GLP-1 agonist—or from a higher semaglutide dose that optimizes your specific pathway. This genetic-first approach eliminates guesswork and accelerates your path to real results.

Comparing Compounded Semaglutide to Brand-Name Wegovy

Wegovy is brand-name semaglutide manufactured by Novo Nordisk, while PlexusDx provides compounded semaglutide injection from licensed 503A compounding pharmacies. Both contain identical semaglutide active ingredients, but compounded versions offer three major advantages: cost savings (starting at $149/month versus $300+ for brand Wegovy), dosing flexibility without price penalties, and faster access in most states. Because compounded medications are made to order, your provider can adjust your weekly dose incrementally—up by 0.25 mg per week if needed—without waiting for the next branded tier or paying more.

Quality and safety are equivalent: all PlexusDx compounding partners are licensed by their state pharmacy boards and follow USP (United States Pharmacopeia) standards. While the FDA doesn't pre-approve compounded drugs the way it does brand medications, the compounding process itself is federally regulated, and the semaglutide powder comes from the same suppliers used by major manufacturers. Many patients switch to compounded semaglutide after stalling on Wegovy simply because the cost savings allow them to stay on therapy longer and make more frequent dose adjustments.

What to Do If You're Not Losing Weight: A Personalized Action Plan

If Wegovy isn't delivering results after 12+ weeks, the first step is ruling out preventable issues: are you in a true calorie deficit? Are you drinking enough water and exercising? Are medications like SSRIs or antihistamines blocking GLP-1 effects? Once lifestyle factors are optimized, consider whether you need a dose increase or a medication switch. A qualified telemedicine provider can review your response and recommend escalation if appropriate.

The second step is genetic testing. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) identifies which peptide pathways your body favors, allowing your provider to choose between semaglutide injection ($149/mo), oral semaglutide ($249/mo), tirzepatide injection ($249/mo), or even the GLP-Squared protocol (a compounded dual-compound combining semaglutide and tirzepatide, starting at $249/mo). This precision-medicine approach has helped thousands of stalled patients break through plateaus. PlexusDx also serves all 50 states with no insurance required, no membership fees, and HSA/FSA eligibility—making expert-guided, genetically informed care accessible and affordable.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long should I wait before concluding that Wegovy isn't working?

Most GLP-1 medications require 8-12 weeks at an adequate dose to show meaningful weight loss. If you haven't reached the standard 1 mg dose and haven't seen progress after 3-4 months, it's reasonable to explore alternatives. PlexusDx providers can accelerate your dosing or switch you to compounded options with more flexible titration schedules.

Does genetic testing predict which GLP-1 medication will work best?

Yes. The Precision Peptide Genetic Test reveals your strongest peptide pathways, helping your provider choose semaglutide, tirzepatide, or dual-compound protocols based on your unique genetic blueprint rather than trial-and-error. Patients with favorable GLP1R variants often respond well to semaglutide, while those with stronger GIP pathway activity may achieve faster results with tirzepatide.

Is compounded semaglutide from PlexusDx as safe as Wegovy?

Yes. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies that meet USP standards and state pharmacy board regulations. The active ingredient is identical to Wegovy; the difference is customizable dosing and significantly lower cost—starting at $149/month versus $300+ for brand name.

What if I need my dose increased every month—will my cost go up?

No. PlexusDx's pricing model is flat per compound: your compounded semaglutide injection stays at $149/month regardless of whether your dose increases from 0.5 mg to 2.4 mg per week. Your dose may need to go up. Your price won't.

Can genetic testing tell me if I have an FTO variant that makes weight loss harder?

Absolutely. The Precision Peptide Genetic Test checks the FTO rs9939609 variant, which influences appetite signaling and baseline metabolic rate. If you carry the higher-risk variant, your provider may recommend earlier intervention with tirzepatide or higher-dose semaglutide to overcome that genetic predisposition. This information helps explain why weight loss might feel harder for you than for others.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves